수면 연관 장애과 중추신경계 염증성 질환

키워드

참고문헌 (50)

1. 김우준, "다발성 경화증", 대한의사협회지, 52(7), pp.665~676 (2009), 대한의사협회
2. 김우준, "New Insights into Neuromyelitis Optica", Journal of Clinical Neurology, 7(3), pp.115~127 (2011), 대한신경과학회
3. Reindl M, "Myelin oligodendrocyte glycoprotein antibodies in neurological disease", Nat Rev Neurol, 15, pp.89~102 (2019)[DOI]
4. Foschi M, "Sleep-related disorders and their relationship with MRI findings in multiple sclerosis", Sleep Med, 56, pp.90~97 (2019)[DOI]
5. Braley TJ, "Sleep disorders in multiple sclerosis", Curr Neurol Neurosci Rep, 16, pp.50~ (2016)[DOI]
6. Lennon VA, "A serum autoantibody marker of neuromyelitis optica : distinction from multiple sclerosis", Lancet, 364, pp.2106~2112 (2004)[DOI]
7. Lennon VA, "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel", J Exp Med, 202, pp.473~477 (2005)[DOI]
8. Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)[DOI]
9. Barnett MH, "Neuromyelitis optica : not a multiple sclerosis variant", Curr Opin Neurol, 25, pp.215~220 (2012)[DOI]
10. Kim SH, "Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder", Mult Scler, 18, pp.1480~1483 (2012)[DOI]
11. Sieminski M, "Restless legs syndrome in multiple sclerosis", Sleep Med Rev, 22, pp.15~22 (2015)[DOI]
12. Rae-Grant AD, "Sensory symptoms of multiple sclerosis : a hidden reservoir of morbidity", Mult Scler, 5, pp.179~183 (1999)[DOI]
13. Auger C, "Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis", Neurology, 65, pp.1652~1653 (2005)[DOI]
14. Aydar G, "Restless legs syndrome in multiple sclerosis", Eur Neurol, 65, pp.302~306 (2011)[DOI]
15. Manconi M, "High prevalence of restless legs syndrome in multiple sclerosis", Eur J Neurol, 14, pp.534~539 (2007)[DOI]
16. Rizzo G, "Brain imaging and networks in restless legs syndrome", Sleep Med, 31, pp.39~48 (2017)[DOI]
17. Bruno E, "Restless legs syndrome and multiple sclerosis : a population based case-control study in Catania, Sicily", Eur J Neurol, 22, pp.1018~1021 (2015)[DOI]
18. Brown LK, "Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen", Sleep, 23, pp.591~594 (2000)
19. Hartmann M, "Restless legs syndrome associated with spinal cord lesions", J Neurol Neurosurg Psychiatry, 66, pp.688~689 (1999)[DOI]
20. Hyun JW, "Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder", Sleep Med, 17, pp.121~123 (2016)[DOI]
21. Ferini-Strambi L, "Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings", J Neurol Sci, 125, pp.194~197 (1994)[DOI]
22. Chen JH, "Sleep disorders in multiple sclerosis in China : clinical, polysomnography study, and review of the literature", J Clin Neurophysiol, 31, pp.375~381 (2014)[DOI]
23. Song Y, "Sleep abnormality in neuromyelitis optica spectrum disorder", Neurol Neuroimmunol Neuroinflamm, 2, pp.e94~ (2015)[DOI]
24. Kaminska M, "Obstructive sleep apnea is associated with fatigue in multiple sclerosis", Mult Scler, 18, pp.1159~1169 (2012)[DOI]
25. Braley TJ, "Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography", Mult Scler Int, 2012, pp.673936~ (2012)[DOI]
26. Tachibana N, "Sleep problems in multiple sclerosis", Eur Neurol, 34, pp.320~323 (1994)[DOI]
27. Beran RG, "Sleep-disordered breathing in multiple sclerosis", Neurology, 80, pp.1354~1355 (2013)[DOI]
28. Côté I, "Impact of sleep disorder treatment on fatigue in multiple sclerosis", Mult Scler, 19, pp.480~489 (2013)[DOI]
29. Pittock SJ, "Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression", Arch Neurol, 63, pp.964~968 (2006)[DOI]
30. Kanbayashi T, "Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications", Arch Neurol, 66, pp.1563~1566 (2009)[DOI]
31. Okuma H, "Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody", Mult Scler, 20, pp.1407~1408 (2014)[DOI]
32. Brass SD, "The underdiagnosis of sleep disorders in patients with multiple sclerosis", J Clin Sleep Med, 10, pp.1025~1031 (2014)[DOI]
33. Stanton BR, "Sleep and fatigue in multiple sclerosis", Mult Scler, 12, pp.481~486 (2006)[DOI]
34. Seok JM, "Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life", PLoS One, 12, pp.e0177230~ (2017)[DOI]
35. 현재원, "Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis", Journal of Clinical Neurology, 16(1), pp.124~130 (2020), 대한신경과학회
36. Kim SM, "Painful tonic spasm in neuromyelitis optica : incidence, diagnostic utility, and clinical characteristics", Arch Neurol, 69, pp.1026~1031 (2012)[DOI]
37. Weissbart SJ, "The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis", Neurourol Urodyn, 36, pp.453~456 (2017)[DOI]
38. Hedström AK, "Shift work at young age is associated with increased risk for multiple sclerosis", Ann Neurol, 70, pp.733~741 (2011)[DOI]
39. Figueiro MG, "A train of blue light pulses delivered through closed eyelids suppresses melatonin and phase shifts the human circadian system", Nat Sci Sleep, 5, pp.133~141 (2013)[DOI]
40. Farez MF, "Melatonin contributes to the seasonality of multiple sclerosis relapses", Cell, 162, pp.1338~1352 (2015)[DOI]
41. Kümpfel T, "Time of interferon-beta 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients", Mult Scler, 13, pp.1138~1145 (2007)[DOI]
42. Koyanagi S, "Alteration of intrinsic biological rhythms during interferon treatment and its possible mechanism", Mol Pharmacol, 62, pp.1393~1399 (2002)[DOI]
43. Mendozzi L, "Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy : an actigraphic study", Mult Scler, 16, pp.238~247 (2010)[DOI]
44. Pokryszko-Dragan A, "Sleep disturbances in patients with multiple sclerosis", Neurol Sci, 34, pp.1291~1296 (2013)[DOI]
45. Bøe Lunde HM, "Poor sleep in patients with multiple sclerosis", PLoS One, 7, pp.e49996~ (2012)[DOI]
46. Nadjar Y, "Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis", Clin Neurol Neurosurg, 113, pp.316~322 (2011)[DOI]
47. Johnson KP, "Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group", Mult Scler, 6, pp.255~266 (2000)[DOI]
48. Neau JP, "Sleep disorders and multiple sclerosis : a clinical and polysomnography study", Eur Neurol, 68, pp.8~15 (2012)[DOI]
49. Svenningsson A, "Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting", PLoS One, 8, pp.e58643~ (2013)[DOI]
50. Penner IK, "Improvement in fatigue during natalizumab treatment is linked to improvement in depression and day-time sleepiness", Front Neurol, 6, pp.18~ (2015)[DOI]

관련 논문AI추천